Attaching Importance to the Diagnosis of Dementia and Improve the Quality of Life：Interpretation of 2018 NICE Dementia： Assessment，Management and Support for People Living with Dementia and Their Carers

doi:10.12114/j.issn.1007-9572.2018.00.299

Abstract

Abstract: With the arrival of ageing population，dementia has become one of the major diseases threatening the health of the elderly.How to make early diagnosis，early treatment and improve the quality of life of patients with dementia is a major problem of governments，medical workers and the public all over the world.This paper interpreted the guideline Dementia：assessment，management and support for people living with dementia and their carers issued by National Institute of Health and Clinical Excellence in UK in 2018，and summarized the key points of diagnosis，treatment and nursing care of dementia in the guideline，aiming to provide scientific basis for the early stratified diagnosis of dementia in primary care settings and to provide reference for pharmacological and other intervention measures.It provides guidelines for carers of dementia and nursing institutions.

Key words: Dementia, Diagnosis, Treatment, Nursing care, Quality of life

摘要： 随着人口老龄化的到来，痴呆已经成为威胁老年人健康的重要疾病之一。如何对痴呆做到早诊断、早治疗及提高患者生活质量是世界各国政府、医务工作者及公众面临的重大难题。本文对英国国家卫生与临床优化研究所（NICE）2018年发布的《痴呆的评估和管理指南》进行分析解读，总结指南中痴呆的诊断、治疗及护理要点，旨在为痴呆的早期分类诊断提供科学根据，为针对痴呆的药物、非药物干预措施提供参考依据，为痴呆的照料者及护理机构提供指导方针。

关键词: 痴呆, 诊断, 治疗, 护理, 生活质量

WANG Wei,GAO Fengqiao,ZHANG Hanwen, et al. Attaching Importance to the Diagnosis of Dementia and Improve the Quality of Life：Interpretation of 2018 NICE Dementia： Assessment，Management and Support for People Living with Dementia and Their Carers[J]. Chinese General Practice, 2018, 21(33): 4037-4040. DOI: 10.12114/j.issn.1007-9572.2018.00.299.
王伟,高凤乔,张瀚文等. 重视痴呆的诊断和生活质量提高——2018 NICE《痴呆的评估和管理指南》解读[J]. 中国全科医学, 2018, 21(33): 4037-4040. DOI: 10.12114/j.issn.1007-9572.2018.00.299.

References

［1］唐钧，刘蔚玮.中国老龄化发展的进程和认识误区［J］.北京工业大学学报（社会科学版），2018，18（4）：8-18.
［2］JIA J，WANG F，WEI C，et al.The prevalence of dementia in urban and rural areas of China［J］.Alzheimers Dement，2014，10（1）：1-9.DOI： 10.1016/j.jalz.2013.01.012.
［3］JIA J，ZHOU A，WEI C，et al.The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese［J］.Alzheimers Dement，2014，10（4）：439-447.DOI：10.1016/j.jalz.2013.09.008.
［4］UK N G A.Dementia：assessment，management and support for people living with dementia and their carers［M］.London： National Institute for Health and Care Excellence ，2018.
［5］DENING T，SANDILYAN M B.Dementia： definitions and types［J］.Nurs Stand，2015，29（37）：37-42.
［6］中国痴呆与认知障碍诊治指南写作组，中国医师协会神经内科医师分会认知障碍疾病专业委员会.2018中国痴呆与认知障碍诊治指南（三）：痴呆的认知和功能评估［J］.中华医学杂志，2018，98（15）：1125-1129.DOI：10.3760/cma.j.issn.0376-2491.2018.15.002.
［7］IHARA R.New diagnostic guidelines for Alzheimer's disease by NIA/AA［J］.Nihon Rinsho，2016，74（3）：386-394.
［8］北京爱琴海乐之技术有限公司.NoteExpress参考文献管理与检索系统［Z/OL］.［2018-08-10］.http：//www.iNoteExpress.com/index_chs.htm.
［9］贾建平，王荫华，魏翠柏，等.中国痴呆与认知障碍诊治指南（五）：痴呆治疗［J］.中华医学杂志，2011，91（14）：940-945.
［10］LI Q，HE S，CHEN Y，et al.Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease［J］.Eur J Med Chem，2018，158：463-477.DOI：10.1016/j.ejmech.2018.09.031.
［11］KRESSIG R W.Dementia of the Alzheimer type： non-drug and drug therapy［J］.Ther Umsch，2015，72（4）：233-238.
［12］KORCZYN A D.Commentary on "Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease"［J］.Alzheimers Dement，2011，7（3）：335-337.
［13］LIM R H，SHARMEEN T.Medicines management issues in dementia and coping strategies used by people living with dementia and family carers： a systematic review［J］.Int J Geriatr Psychiatry，2018.［Epub ahead of print］.DOI：10.1002/gps.4985.
［14］贾建平，王荫华，杨莘，等.中国痴呆与认知障碍诊治指南（六）：痴呆患者护理［J］.中华医学杂志，2011，91（15）：1013-1015.

[1]	YAO Yuzhong, MA Xiaojun, SONG Huan, ZHONG Yu. The Management Effect of Diabetes "1358 model" on Community Diabetes Patients Based on "Precision Management Combining General Care and Specialty Care" [J]. Chinese General Practice, 2023, 26(34): 4308-4314.
[2]	WANG Zhe, DONG Zhihao, ZHENG Hao, KONG Wencheng, ZHANG Yukuan, ZHANG Qiuyue, HAN Jing. Construction of Optimized Treatment Plan of Acupuncture for Migraine Based on Entropy Weight-TOPSIS Method [J]. Chinese General Practice, 2023, 26(34): 4336-4342.
[3]	LI Dianjiang, PAN Enchun, SUN Zhongming, WEN Jinbo, WANG Miaomiao, WU Ming, SHEN Chong. The Current Status and Influencing Factors of Clinical Inertia in Type 2 Diabetes Patients in Community [J]. Chinese General Practice, 2023, 26(34): 4296-4301.
[4]	LIN Kai, YAO Mi, CHEN Zhang, JI Xinxin, LIN Runqi, CHEN Yongsong, Sim MOIRA. Conceptual Framework and Responding Approach of Treatment Burden of Type 2 Diabetes: a Video Recording-based Analysis [J]. Chinese General Practice, 2023, 26(34): 4302-4307.
[5]	WANG Jie, LI Shiming, WEI Shifei, WANG Ningli. Importance of the Role of Primary Care in Myopia Prevention and Control Behavioral Intervention among Children [J]. Chinese General Practice, 2023, 26(33): 4213-4217.
[6]	XIN Gongkai, CONG Xin, YUAN Lei, CHENG Yuetong, NI Cuiping, ZHANG Weiwei, ZHANG Pingping, LIU Yu. Research Progress on Comprehensive Assessment Tools for the Elderly with Dementia [J]. Chinese General Practice, 2023, 26(33): 4103-4109.
[7]	GAO Jing, ZHOU Shangcheng, GAO Sande, ZOU Guanyang, CHEN Yingyao. Health-related Quality of Life and Its Influencing Factors in Patients with Prevention of Disease in Traditionnal Chinese Medicine based on EQ-5D-5L Scale [J]. Chinese General Practice, 2023, 26(32): 4043-4050.
[8]	LU Guangqi, ZHUANG Minghui, ZHU Liguo, GAO Jinghua, WEI Xu, LI Luguang, YU Jie. Interpretation of Best Practices for Minimally Invasive Lumbar Spinal Stenosis Treatment 2.0 (MIST) : Consensus Guidance from the American Society of Pain and Neuroscience (ASPN) in 2022 [J]. Chinese General Practice, 2023, 26(32): 3995-4000.
[9]	LI Qian, ZHANG Yunshu, YAN Baoping, WANG Jian, MA Yanjuan, WANG Yuan, QIN Yingjie, NA Long, REN Zhiyong, SUN Junwei, DENG Huaili, MA Hongjun, QU Xuehui, ZHOU Nan, SI Tianmei. Efficacy and Safety of Risperidone Microspheres for Injection (Ⅱ) in the Treatment of Patients with Acute Schizophrenia [J]. Chinese General Practice, 2023, 26(32): 4007-4012.
[10]	LOU Zheng, LIU Ying, REN Jingjing. Visits for Medically Unspecified Disease in General Internal Medicine Clinics of County General Hospitals [J]. Chinese General Practice, 2023, 26(31): 3945-3950.
[11]	HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901.
[12]	ZHU Lin, GUO Yankui, GAO Chen, CHEN Xuezhi, WANG Fashuai. Efficacy of Western Medicine, Chinese Patent Medicine and Their Combination on Post-stroke Insomnia: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(30): 3823-3832.
[13]	ZHOU Sijing, LUO Bangan, CAO Hui, ZHANG Xi, WANG Dongxin. Epidemiological Characteristics of Dementia and Its Correlation with Multimorbidity among Residents Aged 65 and Above [J]. Chinese General Practice, 2023, 26(29): 3616-3621.
[14]	LIU Ruifang, XU Fangxing, LIU Tongku, ZHOU Yujie, WU Xiaofan. Evaluation of the Efficacy and Safety of "Crowbar Effect" Technique to Facilitate Balloon Crossing Resistant Chronic Total Occlusions Lesions [J]. Chinese General Practice, 2023, 26(29): 3683-3688.
[15]	WANG Yudong, MA Xiaojing, WANG Fang. Influence Mechanism of Capitation for Outpatient Services in Basic Medical Insurance on Medical Expenses Based on the Concept of System Dynamics: a Case Study of Outpatient Payment Mode Reform in Shengzhou, Zhejiang Province [J]. Chinese General Practice, 2023, 26(28): 3496-3501.